Bexagliflozin is an organic compound used as a pharmaceutical raw material. It functions as a sodium-glucose cotransporter 2 (SGLT2) inhibitor and is employed in the manufacture of medications for glycemic control in type 2 diabetes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1118567-05-7
Dapagliflozin Impurity D
pharmaceutical intermediate
Dapagliflozin
pharmaceutical raw material
Dapagliflozin propanediol hydrate
pharmaceutical raw material
Empagliflozin
pharmaceutical raw material
Arginine hydrochloride
pharmaceutical raw material
Tetradonium bromide
pharmaceutical raw material
5-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl]oxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid
pharmaceutical raw material
Quetiapine
active pharmaceutical ingredient
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
BTCRKOKVYTVOLU-SJSRKZJXSA-N
C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl